LONDON BROKER RATINGS: Barclays raises NatWest to 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 377.00p on 14-10-2026 at 17:45:14 |
|---|---|
| Change | 3.80p 1.02% |
| Buy | 379.00p |
| Sell | 378.20p |
| Last Trade: | Unknown 72,611.00 at 377.985p |
| Day's Volume: | 776,856 |
| Last Close: | 377.00p |
| Open: | 382.00p |
| ISIN: | GB00B2PDGW16 |
| Day's Range | 376.60p - 385.60p |
| 52wk Range: | 345.60p - 712.00p |
| Market Capitalisation: | £567.39m |
| VWAP: | 380.66419p |
| Shares in Issue: | 150.50m |
Wh Smith (SMWH) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 72,611 | 377.985p | OTC Trade |
18:43:29 - 14-Oct-26 |
| Unknown* | 425,267 | 382.00p | Negotiated Trade OTC Trade |
16:56:36 - 14-Oct-26 |
| Buy* | 132,744 | 377.00p | Suspected BUY Trade |
16:35:15 - 14-Oct-26 |
| Sell* | 201 | 378.40p | Automatic Execution |
16:29:57 - 14-Oct-26 |
| Sell* | 168 | 378.40p | Automatic Execution |
16:29:57 - 14-Oct-26 |
| Sell* | 206 | 378.40p | Automatic Execution |
16:29:46 - 14-Oct-26 |
| Sell* | 201 | 378.40p | Automatic Execution |
16:29:46 - 14-Oct-26 |
| Sell* | 2 | 378.20p | Automatic Execution |
16:29:41 - 14-Oct-26 |
| Unknown* | 0 | 379.00p | SI Trade |
16:29:36 - 14-Oct-26 |
| Sell* | 24 | 378.20p | Automatic Execution |
16:29:36 - 14-Oct-26 |
Wh Smith (SMWH) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Oct 2026 7:00 am | RNS | Total Voting Rights |
| 16th Sep 2026 7:00 am | RNS | Pre-close Trading Update |
| 1st Sep 2026 7:00 am | RNS | Total Voting Rights |
| 10th Aug 2026 4:27 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 7:00 am | RNS | Total Voting Rights |
| 30th Jun 2026 1:02 pm | RNS | Total Voting Rights |
| 30th Jun 2026 12:59 pm | RNS | Admission to Trading |
| 30th Jun 2026 12:53 pm | RNS | Holding(s) in Company |
| 29th Jun 2026 12:17 pm | RNS | Director/PDMR Shareholding |
| 10th Jun 2026 6:00 pm | RNS | Director/PDMR Shareholding |